VistaGen Therapeutics Inc. (VTGN) |
|
1.27 0.01 (0.79%)
|
03-21 16:00 |
|
Open: |
1.28 |
Pre. Close: |
1.26 |
|
High:
|
1.3094 |
Low:
|
1.25 |
|
Volume:
|
237,554 |
Market Cap:
|
54M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.311 - 1.317 |
1.317 - 1.323 |
|
Low:
|
1.234 - 1.241 |
1.241 - 1.248 |
|
Close:
|
1.259 - 1.27 |
1.27 - 1.28 |
|
|
|
Technical analysis |
as of: 2019-03-21 4:32:13 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.73  One year: 2.04 |
| Support: |
Support1: 1.05 Support2: 0.87 |
| Resistance: |
Resistance1: 1.48 Resistance2: 1.75 |
| Pivot: |
1.23  |
| Moving Average: |
MA(5): 1.29 MA(20): 1.23
MA(100): 1.61 MA(250): 1.44 |
| MACD: |
MACD(12,26): -0.05 Signal(9): -0.07 |
| Stochastic oscillator: |
%K(14,3): 68.02 %D(3): 72.47 |
| RSI: |
RSI(14): 45.64 |
| 52-week: |
High: 2.44 Low: 0.81 Change(%): 8.5 |
| Average Vol(K): |
3-Month: 26425 10-Days: 31170 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.VTGN has closed below upper band by 32.9%. Bollinger Bands are 37.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 30 Oct 2018 20:07:18 Z
Health Care Sector Update for 10/30/2018: AMED,VTGN,PFE,AGN
Tue, 30 Oct 2018 18:27:14 Z
Health Care Sector Update for 10/30/2018: AGN,PFE,VTGN
Tue, 30 Oct 2018 13:27:04 Z
Health Care Sector Update for 10/30/2018: PFE, AGN, VTGN
Wed, 10 Oct 2018 15:20:54 Z
Biotech Stock Roundup: GILD, BIIB Present Data, VTGN Gains on Fast Track Status
Thu, 04 Oct 2018 16:15:04 Z
VistaGen Up on Fast Track Designation to Pain Candidate
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
41.12 |
| Shares Float (M) |
39.67 |
|
% Held by Insiders
|
6.30 |
|
% Held by Institutions
|
11.40 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.240 |
|
EPS Est. Current Year
|
|
|
EPS Est. Next Year
|
|
|
EPS Est. Next Quarter
|
|
|
Forward EPS
|
|
|
Book Value (p.s.)
|
31.170 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-221.1 |
|
Return on Equity (ttm)
|
-402.7 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-13.57 |
|
Levered Free Cash Flow (M)
|
-5.55 |
Stock Valuations |
|
P/E
|
-1.02 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
0.04 |
|
P/S
|
|
|
P/CF
|
-3.85 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2014-08-14 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
